Dr Andrew Jackson


Special clinical interests in Gastrointestinal cancers.



Professional profile

Current NHS post
Hampshire Hospitals NHS Foundation Trust, Basingstoke and University Hospital Southampton NHS Trust.

Training and education
•Undergraduate training, University of Cambridge and St George’s Hospital Medical School, 1989 to 1995.
•Membership of the Royal College of Physicians, 1998.
•Oncology training, pan-Thames training scheme, 1999 to 2006.
•Fellowship of the Royal College of Radiologists, 2003.
•MD, Royal Marsden Hospital and Institute of Cancer Research, 2003 to 2005.

Dr Jackson gained his CCST in clinical oncology in 2006 following training in London and took a post as a clinical lecturer and honorary consultant oncologist at The University of Manchester and Christie Hospital, specialising in upper gastrointestinal cancers, with additional academic interests in image-guided radiotherapy (IGRT) and imaging.

In 2010, Dr Jackson moved to University Hospital Southampton, with two days a week at Hampshire Hospitals NHS Foundation Trust.

He is continuing to pursue his research interest in upper gastrointestinal cancers.

Key achievements
•Radiotherapy technical lead, University Hospital Southampton.
•Chief investigator, ROCOCO (Radiotherapy and Olaparib in Combination for Oesophageal Cancer) phase 1 dose escalation study. Awarded funding by CRUK New Agents Committee, January 2011.
•Chief investigator, Biostent study (Biodegradable stents plus palliative radiotherapy for oesophageal cancer). Phase 2 study, awarded funding by NIHR Research for Patient Benefit program.
•Principal investigator, Christie Hospital, Manchester: PACER (Locally Advanced pancreatic cancer: Phase II study of Cetuximab and 3-D conformal Image Guided Radiotherapy). Three centres NCRN badged study.
•Co-investigator, Christie Hospital, Manchester: ‘A real-time visual feedback device for reducing patient movement during radiotherapy’, NIHR New and Emerging Applications of Technology (NEAT) award 2008.
•Principal investigator, Christie Hospital, Manchester: DCE-MRI in oesophageal cancer: a pilot study. University of Manchester Magnetic Resonance Imaging Facility.

Awards and prizes
Rohan Williams Medal for FRCR 2003



  • Oncology